Patient-derived high functional avidity TCR empowers diverse T cell subsets for tumour immunotherapy. [PDF]
Gao F +14 more
europepmc +1 more source
Enhanced replication and immunogenicity of a genome-modified non-replicating vaccinia virus Tiantan strain for robust low-dose protection in mice. [PDF]
Ren J +9 more
europepmc +1 more source
Synergistic Oncolytic Effect of HSVtk- and IL-15Rα-Armed Vaccinia Viruses Inducing Systemic Antitumor Immunity. [PDF]
Alekseeva ON +11 more
europepmc +1 more source
Olvi-Vec oncolytic immunotherapy and reversal of platinum resistance in ovarian cancer. [PDF]
Yu YA +3 more
europepmc +1 more source
Vaccinia virus and Monkeypox virus neutralizing and antigen-binding antibodies following subcutaneous and reduced intradermal doses of an MVA vaccine. [PDF]
Moss B +6 more
europepmc +1 more source
IL-23-engineered oncolytic vaccinia virus enhances pancreatic cancer control through inflammasome-driven Th17-skewed CD4<sup>+</sup> T-cell responses. [PDF]
Guo Y +14 more
europepmc +1 more source
Correction: Hsu et al. Vaccinia Virus: Mechanisms Supporting Immune Evasion and Successful Long-Term Protective Immunity. <i>Viruses</i> 2024, <i>16</i>, 870. [PDF]
Hsu J, Kim S, Anandasabapathy N.
europepmc +1 more source
Cellular miR-24-3p inhibits vaccinia virus replication by targeting kinesin-like protein KIF21B. [PDF]
Jiao P +9 more
europepmc +1 more source
The Pathogenesis of Atypical Clinical Presentations of Monkeypox Virus Infections. [PDF]
Kankanamge LHR +4 more
europepmc +1 more source

